Skip to content
Saturday, November 7, 2026
Discover expert reviews, strategies, and updates on the new…

{‘She lacks little experience’: this American medical community prepares for Dr. Høeg's tenure at the FDA.

Given that America proceeds with unprecedented revisions to its vaccination guidelines, one figure has surfaced in a surprising turn: Dr. Tracy Beth Høeg, a US-based sports physician and public health researcher who rose to prominence by expressing skepticism about Covid shots during the pandemic and has concentrated on potential fatalities after Covid vaccination in her brief position at the US Food and Drug Administration (FDA).

Scheduled Shifts to Childhood Immunization Program

Health officials had intended to announce major changes to the childhood vaccination calendar in December, aligning the US with Denmark’s immunization schedule, it is understood – a substantial departure that would put the US out of step with much of the global community with little proof for benefit. This reveal has been delayed until the next year.

Rather than Vinay Prasad, Tracy Beth Høeg is scheduled to present at the gathering. She was recently named temporary leader of the FDA’s drug evaluation center, the fifth person to head the division this calendar year.

A Shift at the Agency

Høeg's temporary position could signify a closer partnership between the pharmaceutical and biologics branches as Dr. Høeg and Dr. Prasad strengthen their influence at the regulatory agency – and it points to a increased emphasis upon rolling back long-standing immunizations at the FDA.

Dr. Høeg has often pushed for halting some childhood vaccine recommendations in the US in order to be more similar to Denmark, a country with nationalized medicine and a population roughly the population of Wisconsin’s.

So far public appearances, she has persisted in emphasizing on immunizations – traditionally the purview of Dr. Prasad, head of the FDA’s vaccine center – as opposed to medication approval.

Concerns Over Qualifications

Høeg has no apparent background in pharmaceutical research, approval processes or leadership, which has been customary for former heads of the biologics center. She has worked at the FDA as a senior adviser to the FDA chief and the vaccine center since March.

“She appears not to have the requisite experience” for leading the CDER, stated Dr. Jonathan Howard. “She has not conducted a randomized controlled trial. She lacks experience in managing a sizeable institution. She has no expertise in pharmaceutical oversight.”

Previous commissioners of the center would “understand laws and regulations and the science of medication creation”, said a former acting FDA commissioner. “Frankly, she has not acquired the type of experience that previous people who ran CBER have had.”

The drug center has an vast workload at the agency, she emphasized.

“The public just pays attention on the new drug program, but the generic drug division clears a multitude of generic drugs. There is also a biosimilars division, OTC medication office and so forth, and all of those have to be looked after,” she explained. “The responsibility you overlook, that is the part that I always told people is going to cause problems.”

Furthermore, a major administrative component to the role, which supervises in excess of 5,000 staff members. “It’s a enormous administrative position, if you perform it correctly,” the former official said.

Agency Reaction and Disputed Policies

When asked about inquiries about Dr. Høeg's fitness for the role and whether this appointment indicates increased cooperation among agency officials on immunizations, a press secretary stated that the “questions are based on flawed presumptions”.

“Her resume matches the responsibilities of her position,” the spokesperson explained, pointing to the months Høeg spent guiding the agency head on “pharmaceutical safety and oversight research, including computerized risk analysis and vaccine surveillance”.

As acting director, Dr. Høeg inherits the commissioner’s recently launched priority voucher program, a controversial rapid drug-approval program that reportedly worried her former heads. “By what process are these medications being picked for this expedited pathway? Who takes the calls?” Dr. Howard asked. “There is a lot of lack of transparency occurring at the FDA right now.”

Overall, he stated, “the FDA looks to be trending towards more relaxed oversight of pharmaceuticals, aside from vaccines.”

Public Track Record on Vaccines

Concerning immunizations, Dr. Høeg has a more established, if problematic, history, Howard have noted. She released a analysis using unconfirmed volunteer-provided data to estimate the incidence of myocarditis after Covid vaccination. She counseled the state of Florida chief medical officer Joseph Ladapo, who reportedly have altered data to indicate COVID-19 vaccines are more dangerous than they are.

Among her “policy goals” for the current federal leadership encompassed altering regulations for recently developed shots and ending “unnecessary” immunizations, she stated after the election on a online show. At the FDA, Dr. Høeg has according to sources floated the idea of preventing adolescent males from getting COVID-19 vaccinations.

“She is an complete dogmatist who begins with her beliefs and reverse-engineers to fit the science in a highly deceptive, dishonest way,” Howard argued.

Taking Control and a “Push for Payback”

Dr. Høeg joined other contrarians, {like|

Written by

Joseph Maxwell

A seasoned gaming analyst with over a decade of experience in casino trends and slot machine mechanics, dedicated to helping players succeed.

Fresh Slots Station

Type to search articles.